Search results
AstraZeneca asks the FDA to let adults give themselves the annual flu vaccine
Yahoo Finance· 6 months agoAstraZeneca (AZN) is asking the FDA to approve its nasal flu vaccine, FluMist, for use at home — a...
AstraZeneca claims allegations Covid jab is defective are ‘confused’ and ‘wrong in law’
The Telegraph via Yahoo News· 5 months agoAstraZeneca said three billion doses of the vaccine had been supplied to 180 countries and saved...
Vaccines Helped to Control COVID-19. But the Global Rollout Is Still Broken
Time via Yahoo News· 1 year agoA Kenyan health worker receives a dose of the Oxford/AstraZeneca vaccine, part of the COVAX...
AstraZeneca-Oxford University Partnered Nasal COVID-19 Vaccine Flunks Human Trial
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) and Oxford University scientists said that the initial testing of its...
Major COVID vaccine study finds heart risks are rare — and the real threat is being unvaccinated
Salon via Yahoo News· 2 months agoCOVID-19 Coronavirus Vaccine Eric Lee for The Washington Post via Getty Images Even while the...
FDA Panel Endorses AstraZeneca (AZN), Sanofi's RSV Antibody
Zacks via Yahoo Finance· 11 months agoAstraZeneca AZN and Sanofi SNY announced that an FDA advisory committee recommended approving the...
The Zacks Analyst Blog Highlights AstraZeneca, Merck, Roche, J&J, and Pfizer
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – May 31, 2022 – Zacks.com announces the list of stocks featured...
Father with brain injury sues pharma giant over Covid vaccine ‘defect’
PA Media: Money via Yahoo Finance· 5 months agoA father-of-two who claims he suffered a brain injury after receiving the AstraZeneca Covid-19...
European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine
Benzinga via Yahoo Finance· 1 year agoThe European Medicines Agency (EMA) has granted full Marketing Authorisation to AstraZeneca Plc's...
Nasal COVID vaccine fails to offer desired protection in testing
The Hill via Yahoo News· 2 years agoA recent clinical trial has found less-than-promising results for a nasally administered version of...